한글목차

하이드로콜로이드 드레싱 시장 규모는 2025년 18억 337만 달러에서 2034년에는 28억 2,169만 달러에 달할 것으로 예측되고 있으며, 2026-2034년에 CAGR 5.1%로 성장할 전망입니다.

하이드로콜로이드 드레싱 시장은 첨단 상처 치료 솔루션에 대한 수요가 증가하면서 괄목할 만한 성장이 예상됩니다. 하이드로콜로이드 드레싱은 습윤 환경을 유지하고 회복을 촉진하는 특성으로 인해 만성 상처, 외과적 상처, 화상 등 다양한 유형의 상처 관리에 널리 활용되고 있습니다. 당뇨병, 욕창 등 만성질환의 유병률 증가와 고령화가 진행되면서 하이드로콜로이드 드레싱 수요를 견인하고 있습니다. 의료진들이 환자의 치료 성과 향상과 치료 기간 단축을 목표로 하고 있는 가운데, 하이드로콜로이드 드레싱 시장은 확대될 것으로 예측됩니다.

기술 혁신은 하이드로콜로이드 드레싱 시장 전망를 형성하는 데 중요한 역할을 하고 있습니다. 항균제 배합, 접착력 향상 등 드레싱 제형의 혁신으로 효과와 사용 편의성이 향상되고 있습니다. 또한 첨단 창상 평가 기술의 개발로 의료진은 치유 과정을 보다 효과적으로 모니터링할 수 있게 되었습니다. 하이드로콜로이드 드레싱 시장은 제조업체들이 연구개발에 지속적으로 투자하면서 병원, 외래진료소, 재택의료 등 다양한 의료현장에서 채용이 확대될 것으로 예측됩니다.

또한 환자 중심의 치료와 교육에 대한 관심이 높아지면서 하이드로콜로이드 드레싱 시장의 성장 궤도에 영향을 미치고 있습니다. 환자들이 상처 관리에 적극적으로 참여함에 따라 사용하기 쉽고 명확한 사용법이 명시된 제품에 대한 수요가 증가하고 있습니다. 이러한 추세에 따라 환자들이 주도적으로 상처 관리를 할 수 있도록 돕는 교육 자료와 지원 시스템을 개발하기 위해 제조업체와 의료 프로바이더 간의 협력이 진행되고 있습니다. 시장이 계속 진화하는 가운데, 기술 통합, 환자 참여, 효과적인 상처 관리가 성공의 열쇠가 될 것입니다.

목차

제1장 서론

제2장 개요

제3장 시장 변수, 동향, 프레임워크

제4장 세계의 하이드로콜로이드 드레싱 시장 : 제품 유형별

제5장 세계의 하이드로콜로이드 드레싱 시장 : 용도별

제6장 세계의 하이드로콜로이드 드레싱 시장 : 최종사용자별

제7장 세계의 하이드로콜로이드 드레싱 시장 : 지역별

제8장 경쟁 구도

제9장 기업 개요

영문목차

The Hydrocolloid Dressing Market size is expected to reach USD 2821.69 Million in 2034 from USD 1803.37 Million (2025) growing at a CAGR of 5.1% during 2026-2034.

The Hydrocolloid Dressing Market is poised for significant growth as the demand for advanced wound care solutions increases. Hydrocolloid dressings are widely used for managing various types of wounds, including chronic wounds, surgical wounds, and burns, due to their ability to maintain a moist healing environment and promote faster recovery. The rising prevalence of chronic conditions, such as diabetes and pressure ulcers, coupled with an aging population, is driving the demand for hydrocolloid dressings. As healthcare providers seek to improve patient outcomes and reduce healing times, the market for hydrocolloid dressings is expected to flourish.

Technological advancements are playing a crucial role in shaping the future of the hydrocolloid dressing market. Innovations in dressing formulations, such as the incorporation of antimicrobial agents and enhanced adhesive properties, are improving the effectiveness and usability of hydrocolloid dressings. Additionally, the development of advanced wound assessment technologies is enabling healthcare professionals to monitor healing progress more effectively. As manufacturers continue to invest in research and development, the hydrocolloid dressing market is likely to see increased adoption across various healthcare settings, including hospitals, outpatient clinics, and home healthcare.

Moreover, the growing emphasis on patient-centered care and education is influencing the hydrocolloid dressing market's growth trajectory. As patients become more involved in their wound care management, there is a rising demand for products that are easy to use and provide clear instructions for application. This trend is driving collaboration between manufacturers and healthcare providers to develop educational resources and support systems that empower patients to take an active role in their wound care. As the market continues to evolve, the integration of technology, patient engagement, and effective wound management will be key drivers of success.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Amorphous Hydrocolloid Dressings
• Fibrous Hydrocolloid Dressings
• Others
• Distribution Channel
• Hospital pharmacies
• Retail pharmacies
• Online pharmacies & e-commerce
• Others

By Application

• Diabetic Foot Ulcers
• Pressure Ulcers
• Venous Leg Ulcers
• Surgical & Traumatic Wounds
• Burns
• Others

By End-User

• Hospitals
• Clinics
• Homecare Settings
• Others

COMPANIES PROFILED

• 3M Company, , Smith Nephew plc, ConvaTec Group Plc, Coloplast AS, Medline Industries Inc, Cardinal Health Inc, B Braun Melsungen AG, Paul Hartmann AG, Mlnlycke Health Care AB, Hollister Incorporated, Integra LifeSciences Corporation, Lohmann Rauscher GmbH Co KG, Advanced Medical Solutions Group plc

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HYDROCOLLOID DRESSING MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Amorphous Hydrocolloid Dressings Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Fibrous Hydrocolloid Dressings Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Distribution Channel Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Hospital pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Retail pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Online pharmacies & e-commerce Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.9. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HYDROCOLLOID DRESSING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Diabetic Foot Ulcers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Pressure Ulcers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Venous Leg Ulcers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Surgical & Traumatic Wounds Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Burns Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HYDROCOLLOID DRESSING MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Homecare Settings Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HYDROCOLLOID DRESSING MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Application
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Application
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Application
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Application
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Application
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL HYDROCOLLOID DRESSING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Smith & Nephew Plc
  • 9.2.2 ConvaTec Group Plc
  • 9.2.3 Coloplast A/S
  • 9.2.4 Medline Industries Inc
  • 9.2.5 Cardinal Health Inc
  • 9.2.6 B. Braun Melsungen AG
  • 9.2.7 Paul Hartmann AG
  • 9.2.8 MA¶Lnlycke Health Care AB
  • 9.2.9 Hollister Incorporated
  • 9.2.10 Integra LifeSciences Corporation
  • 9.2.11 Lohmann & Rauscher GmbH & Co. KG
  • 9.2.12 Advanced Medical Solutions Group Plc